Woodline Partners LP Karuna Therapeutics, Inc. Transaction History

Woodline Partners LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $53.9 Million - $106 Million	334,751 Added 1473.25%	357,473 $113 Million
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $4.51 Million - $5.97 Million	-27,378 Reduced 54.65%	22,722 $3.84 Million
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $8.83 Million - $12 Million	50,100 New	50,100 $10.9 Million
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $16.4 Million - $36.7 Million	-132,150 Reduced 90.06%	14,585 $3.28 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $5.71 Million - $8.71 Million	60,745 Added 70.64%	146,735 $18.6 Million

Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $6.85 Million - $9.16 Million	69,226 Added 412.94%	85,990 $10.9 Million
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $674,461 - $971,702	6,096 Added 57.14%	16,764 $2.2 Million
Q1 2021 May 17, 2021	BUY	$95.46 - $133.08 $1.02 Million - $1.42 Million	10,668 New	10,668 $1.28 Million

333K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.